The following is a current list of our studies at the Asthma Research Center. All studies are open for enrollment, unless otherwise noted. The Asthma Research Center runs multiple studies and each study varies in duration and compensation is up to $1,180 for your time and effort. To see if you are eligible for any of our studies, please contact us.
Results 1 - 4 of 10 total studies
Page 1 of 3 123 >> next
Genetics and its Effect on the Treatment of Exercise-Induced Asthma
The purpose of this study is to find out how one’s genetic background influences the therapeutic response to salmeterol (Serevent®) for treatment of exercise-induced asthma. You may be eligible if you have asthma and are between the ages of 18-50 years. Participants will be seen by a medical doctor and receive study related testing and asthma medications at no cost. It involves 3-4 study visits over a 4-week period.
more information on becoming a participant
Severe Asthma Study: Imatinib
This research study will look at patients with severe persistent asthma. The research study involves 17 visits over a 28 week period and involves bronchoscopies. The study’s purpose is to assess the safety and effectiveness of an investigational drug called imatinib in the treatment of asthma. Participants will receive asthma medication and imatinib at no cost.
more information on becoming a participant
Xolair Bronchoscopy Study
This research study will look at patients with moderate to severe persistent asthma. One group will receive standard treatment plus subcutaneous injections of XOLAIR for 80 weeks, while the other group will receive standard treatment plus placebo injections (contains no active medication) for 80 weeks. This study involves bronchoscopies. All subjects will receive their inhalers, like Advair, Flovent, and Albuterol, at no cost for the duration of the study.
more information on becoming a participant
Eosinophilic Asthma Study
The Asthma Research Center at Brigham and Women’s Hospital is recruiting asthmatics aged 18-75 who use Inhaled Corticosteroids (i.e. Flovent 220 or Advair 500/50) and at least one other asthma medication to control their symptoms. The research study involves 7 visits over an 18 weeks period and involves 4 infusions. The study’s purpose is to assess the safety and effectiveness of a new medication in the treatment of asthma.
more information on becoming a participant
more information on becoming a participant
